12 research outputs found
Nitinol-Based Nanotubular Arrays with Controlled Diameters Upregulate Human Vascular Cell ECM Production
Current
approaches to reducing restenosis do not balance the reduction
of vascular smooth muscle cell proliferation with the increase in
the healing of the endothelium. Building on our previous work, we
present our study on the effects of Nitinol-based nanotubular coatings
with different nanotube diameters on the reduction of restenosis.
Here, we demonstrate that the nanotubular coatings reduced primary
human aortic smooth muscle cell (HASMC) proliferation and increased
the migration (by more than 4 times), collagen (by 2–3 times
per cell) and elastin (by 5–8 times per cell) production of
primary human aortic endothelial cells (HAEC). Furthermore, a significant
increase in elastin and soluble collagen production of HAEC was observed
with an increase in nanotube diameter. Our findings suggest that nanotubes-coated
Nitinol may provide a surface conducive for HAEC reendothelialization
while reducing the proliferation of HASMC
Nanoengineered Stent Surface to Reduce In-Stent Restenosis <i>in Vivo</i>
In-stent restenosis (ISR) is the
leading cause of stent failure and is a direct result of a dysfunctional
vascular endothelium and subsequent overgrowth of vascular smooth
muscle tissue. TiO<sub>2</sub> nanotubular (NT) arrays have been shown
to affect vascular endothelial cells (VECs) and vascular smooth muscle
cells (VSMCs) <i>in vitro</i> by accelerating VEC cell proliferation
and migration while suppressing VSMCs. This study investigates for
the first time the potentially beneficial effects of TiO<sub>2</sub> NT arrays on vascular tissue <i>in vivo</i>. TiO<sub>2</sub> NT arrays (NT diameter: 90 ± 5 nm, height: 1800 ± 300
nm) were grown on the surface of titanium stents and characterized
in terms of surface morphology and stability. Stents were implanted
into the iliofemoral artery using an overinflation model (rabbit).
After 28 days, stenosis rates were determined. The data show a statistically
significant reduction of stenosis by 30% compared to the control.
Tissue in the presence of TiO<sub>2</sub> NTs appears more mature,
and less neointima is present between struts. In addition, the extra
cellular matrix secreted by cells at the interface of the NT arrays
shows complete integration into the nanostructured surface. These
results document the accelerated restoration of a functional endothelium
in the presence of TiO<sub>2</sub> NT arrays and substantiate their
beneficial impact on vascular tissue <i>in vivo</i>. Our
findings suggest that TiO<sub>2</sub> NT arrays can be used as a drug-free
approach for keeping stents patent long-term and have the potential
to address ISR
Nitinol-Based Nanotubular Coatings for the Modulation of Human Vascular Cell Function
In
this study, we describe the synthesis of an upright nanotubular
coating with discrete, exposed nanotubes on top of superelastic Nitinol
via anodization and characterization of the surface elemental composition
and nickel release rates. We demonstrate, for the first time, that
this coating could improve re-endothelialization by increasing the
cell spreading and migration of primary human aortic endothelial cells
on Nitinol. We also show the potential for reducing neointimal hyperplasia
by decreasing the proliferation and expression of collagen I and MMP-2
in primary human aortic smooth muscle cells (HASMC). Furthermore,
we did not observe the nanotubular surface to induce inflammation
through ICAM-1 expression in HASMC as compared to the flat control.
This coating could be used to improve Nitinol stents by reducing restenosis
rates and, given the extensive use of Nitinol in other implantable
devices, act as a generalized coating strategy for other medical devices
Nanostructured Thin Film Polymer Devices for Constant-Rate Protein Delivery
Herein long-term delivery of proteins from biodegradable
thin film
devices is demonstrated, where a nanostructured polymer membrane controls
release. Protein was sealed between two poly(caprolactone) films,
which generated the thin film devices. Protein release for 210 days
was shown <i>in vitro</i>, and stable activity was established
through 70 days with a model protein. These thin film devices present
a promising delivery platform for biologic therapeutics, particularly
for application in constrained spaces
Novel Functionalization of Discrete Polymeric Biomaterial Microstructures for Applications in Imaging and Three-Dimensional Manipulation
Adapting
ways to functionalize polymer materials is becoming increasingly important
to their implementation in translational biomedical sciences. By tuning
the mechanical, chemical, and biological qualities of these materials,
their applications can be broadened, opening the door for more advanced
integration into modern medical techniques. Here, we report on a method
to integrate chemical functionalizations into discrete, microscale
polymer structures, which are used for tissue engineering applications,
for in vivo localization, and three-dimensional manipulation. Iron
oxide nanoparticles were incorporated into the polymer matrix using
common photolithographic techniques to create stably functional microstructures
with magnetic potential. Using magnetic resonance imaging (MRI), we
can promote visualization of microstructures contained in small collections,
as well as facilitate the manipulation and alignment of microtopographical
cues in a realistic tissue environment. Using similar polymer functionalization
techniques, fluorine-containing compounds were also embedded in the
polymer matrix of photolithographically fabricated microstructures.
The incorporation of fluorine-containing compounds enabled highly
sensitive and specific detection of microstructures in physiologic
settings using fluorine MRI techniques (<sup>19</sup>F MRI). These
functionalization strategies will facilitate more reliable noninvasive
tracking and characterization of microstructured polymer implants
as well as have implications for remote microstructural scaffolding
alignment for three-dimensional tissue engineering applications
Shape Effect in the Design of Nanowire-Coated Microparticles as Transepithelial Drug Delivery Devices
While the oral drug delivery route has traditionally been the most popular among patients, it is estimated that 90% of therapeutic compounds possess oral bioavailability limitations. Thus, the development of novel drug carriers for more effective oral delivery of therapeutics is an important goal. Composite particles made by growing nanoscopic silicon wires from the surface of narrowly dispersed, microsized silica beads were previously shown to be able to (a) adhere well onto the epithelium by interdigitating their nanowires with the apical microvilli and (b) increase the permeability of Caco-2 cell monolayers with respect to small organic molecules in direct proportion to their concentration. A comparison between the effects of spherical and planar particle morphologies on the permeability of the epithelial cell layer <i>in vitro</i> and <i>in vivo</i> presented the subject of this study. Owing to their larger surface area, the planar particles exhibited a higher drug-loading efficiency than their spherical counterparts, while simultaneously increasing the transepithelial permeation of a moderately sized model drug, insulin. The insulin elution profile for planar nanowire-coated particles displayed a continual increase in the cumulative amount of the released drug, approaching a constant release rate for a 1–4 h period of the elution time. An immunohistochemical study confirmed the ability of planar silica particles coated with nanowires to loosen the tight junction of the epithelial cells to a greater extent than the spherical particles did, thus, enabling a more facile transport of the drug across the epithelium. Transepithelial permeability tests conducted for model drugs ranging in size from 0.4 to 150 kDa yielded three categories of molecules depending on their permeation propensities. Insulin belonged to the category of molecules deliverable across the epithelium only with the assistance of nanowire-coated particles. Other groups of drugs, smaller and bigger, respectively, either did not need the carrier to permeate the epithelium or were not able to cross it even with the support from the nanowire-coated particles. Bioavailability of insulin orally administered to rabbits was also found to be increased when delivered in conjunction with the nanowire-coated planar particles
Efficient Targeting of Fatty-Acid Modified Oligonucleotides to Live Cell Membranes through Stepwise Assembly
Lipid
modifications provide efficient targeting of oligonucleotides
to live cell membranes in a range of applications. Targeting efficiency
is a function of the rate of lipid DNA insertion into the cell surface
and its persistence over time. Here we show that increasing lipid
hydrophobicity increases membrane persistence, but decreases the rate
of membrane insertion due to the formation of nonproductive aggregates
in solution. To ameliorate this effect, we split the net hydrophobicity
of the membrane anchor between two complementary oligonucleotides.
When prehybridized in solution, doubly anchored molecules also aggregate
due to their elevated hydrophobicity. However, when added sequentially
to cells, aggregation does not occur so membrane insertion is efficient.
Hybridization between the two strands locks the complexes at the cell
surface by increasing net hydrophobicity, increasing their total concentration
and lifetime, and dramatically improving their utility in a variety
of biomedical applications
Fabrication of Micropatterned Polymeric Nanowire Arrays for High-Resolution Reagent Localization and Topographical Cellular Control
Herein,
we present a novel approach for the fabrication of micropatterned
polymeric nanowire arrays that addresses the current need for scalable
and customizable polymer nanofabrication. We describe two variations
of this approach for the patterning of nanowire arrays on either flat
polymeric films or discrete polymeric microstructures and go on to
investigate biological applications for the resulting polymeric features.
We demonstrate that the micropatterned arrays of densely packed nanowires
facilitate rapid, low-waste drug and reagent localization with micron-scale
resolution as a result of their high wettability. We also show that
micropatterned nanowire arrays provide hierarchical cellular control
by simultaneously directing cell shape on the micron scale and influencing
focal adhesion formation on the nanoscale. This nanofabrication approach
has potential applications in scaffold-based cellular control, biological
assay miniaturization, and biomedical microdevice technology
Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices
Cell-encapsulating devices can play an important role in advancing the types of tissue available for transplantation and further improving transplant success rates. To have an effective device, encapsulated cells must remain viable, respond to external stimulus, and be protected from immune responses, and the device itself must elicit a minimal foreign body response. To address these challenges, we developed a micro- and a nanoporous thin-film cell encapsulation device from polycaprolactone (PCL), a material previously used in FDA-approved biomedical devices. The thin-film device construct allows long-term bioluminescent transfer imaging, which can be used for monitoring cell viability and device tracking. The ability to tune the microporous and nanoporous membrane allows selective protection from immune cell invasion and cytokine-mediated cell death <i>in vitro</i>, all while maintaining typical cell function, as demonstrated by encapsulated cells’ insulin production in response to glucose stimulation. To demonstrate the ability to track, visualize, and monitor the viability of cells encapsulated in implanted thin-film devices, we encapsulated and implanted luciferase-positive MIN6 cells in allogeneic mouse models for up to 90 days. Lack of foreign body response in combination with rapid neovascularization around the device shows promise in using this technology for cell encapsulation. These devices can help elucidate the metrics required for cell encapsulation success and direct future immune-isolation therapies
Nanostructure-Mediated Transport of Biologics across Epithelial Tissue: Enhancing Permeability via Nanotopography
Herein, we demonstrate that nanotopographical cues can
be utilized
to enable biologics >66 kDa to be transported across epithelial
monolayers.
When placed in contact with epithelial monolayers, nanostructured
thin films loosen the epithelial barrier and allow for significantly
increased transport of FITC-albumin, FITC-IgG, and a model therapeutic,
etanercept. Our work highlights the potential to use drug delivery
systems which incorporate nanotopography to increase the transport
of biologics across epithelial tissue